|
Administration
Should be taken with food. Take just before meals.
|
|
Contraindications
Inflammatory bowel disease; GI obstruction or patients predisposed to it; conditions which may deteriorate as a result of increased gas formation eg, hernia; severe ketosis; diabetic coma or pre-coma; severe infection; hypersensitivity; pregnancy; lactation. Not to be used as monotherapy in IDDM.
|
|
Special Precautions
History of laparotomy or ileus. Roemheld's syndrome, stenosis, severe hepatic or renal impairment. Child <18 yr; elderly. Monitor LFT. Treat hypoglycaemic episodes with glucose (not with sucrose).
|
|
Adverse Reactions
Flatulence; abdominal distension; diarrhoea; pain; skin reactions; hypoglycemia; increased LFT.
Potentially Fatal: Hepatotoxicity. |
|
Drug Interactions
May enhance effects of other antidiabetics including insulin.
|
|
CIMS Class
|
|
ATC Classification
A10BF03 - voglibose ; Belongs to the class of alpha glucosidase inhibitors. Used in the treatment of diabetes.
|
Sign Out
